Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain

BACKGROUND AND OBJECTIVE: Ampreloxetine is a novel norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension. The objectives of this analysis were to define the pharmacokinetics of once-daily oral ampreloxetine and provide dose recommendatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanodia, Jitendra, Lo, Arthur, Baldwin, R. Michael, Graham, Richard A., Bourdet, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808980/
https://www.ncbi.nlm.nih.gov/pubmed/32856281
http://dx.doi.org/10.1007/s40262-020-00918-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808980/
https://www.ncbi.nlm.nih.gov/pubmed/32856281
http://dx.doi.org/10.1007/s40262-020-00918-7

Ejemplares similares